The C-peptide test measures C-peptide levels in blood, which reflects endogenous insulin production by the pancreas. When the pancreas produces insulin, it produces equal amounts of C-peptide. Since C-peptide isn’t extracted by the liver and isn’t included in injected insulin, measuring it provides information about how much insulin the body is making versus what’s being given as medication. The c peptide test is most useful for distinguishing type 1 from type 2 diabetes and characterizing pancreatic function. This guide covers what C-peptide measures, normal ranges, and clinical applications.
What C-peptide indicates
C-peptide is a byproduct of insulin synthesis. The pancreas produces proinsulin, which is cleaved into insulin and C-peptide in equal proportions. C-peptide enters the bloodstream alongside insulin but has different metabolism — it’s cleared by the kidneys rather than the liver.
Because injected insulin doesn’t contain C-peptide, measuring C-peptide separates endogenous (pancreas-produced) insulin from injected insulin. This is critical for understanding pancreatic function in patients with diabetes who may be taking insulin.
Reference ranges
- Fasting C-peptide: 0.5-2.0 ng/mL typical adult range
- Stimulated C-peptide (after meal or glucagon): higher
Type 1 vs type 2 diabetes
The most common clinical use:
Type 1 diabetes: Beta cell destruction means little or no endogenous insulin production. C-peptide is typically very low or undetectable.
Type 2 diabetes: Insulin resistance with relatively preserved insulin production initially. C-peptide is normal or elevated. As type 2 diabetes progresses, beta cell function declines and C-peptide can decrease.
The distinction matters for treatment — type 1 patients need insulin replacement; type 2 patients have multiple treatment options including non-insulin medications. C-peptide combined with antibody testing (GAD65, IA-2, ZnT8) helps clarify the diagnosis when atypical features are present.
Other clinical uses
Hypoglycemia evaluation: C-peptide during a hypoglycemic episode helps determine cause. Elevated C-peptide with low glucose suggests insulinoma or sulfonylurea use; low C-peptide with low glucose suggests exogenous insulin (potentially surreptitious use).
Pancreatic function assessment: Useful for evaluating pancreatic transplant function or beta cell preservation in clinical trials.
Diabetes type clarification: Some patients have features of both type 1 and type 2; C-peptide and antibody testing helps clarify.
Frequently Asked Questions
Do I need to fast for C-peptide?
Yes for fasting C-peptide. Stimulated tests follow specific protocols.
What does low C-peptide mean?
Low endogenous insulin production. Typical of type 1 diabetes or advanced type 2 diabetes.
What does high C-peptide mean?
High endogenous insulin production. Suggests insulin resistance, type 2 diabetes early stages, or insulinoma.
Is C-peptide affected by injected insulin?
No. Injected insulin doesn’t contain C-peptide, so C-peptide measures only endogenous production.
When is C-peptide testing ordered?
Distinguishing type 1 from type 2 diabetes, hypoglycemia evaluation, and assessing pancreatic function. Not routine in straightforward diabetes management.
The bottom line on the C-peptide test
C-peptide testing measures endogenous insulin production and is most useful for distinguishing type 1 from type 2 diabetes, evaluating hypoglycemia, and assessing pancreatic function. For routine diabetes management, glucose and A1c testing are typically sufficient. Discuss with your healthcare provider when this specialized test is appropriate.